SHPH
Shuttle Pharmaceuticals Holdings, Inc. · Healthcare
Insiders bought $141K of Shuttle Pharmaceuticals Holdings, Inc. in the last 12 months
1 insider bought on 2 days.
$141KBought, 12 mo
$505KSold, 12 mo
$23.2MMarket cap
SHPH over the last year
Largest buyers, last 12 months
SHPH after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
5 insider filings since 2026, newest first
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.